Both hepatic IGF-1-deficient mice and ALS knockout mice exhibit relatively normal growth and development, despite having 75% and 65% reductions in serum IGF-1 levels, respectively. This evidence concerns the gene IGF1 and amyotrophic lateral sclerosis.